ICMR Rings Belly Alarm as India Battles Rising Waistlines

IMT News Desk
IMT News Desk
· 2 min read
ICMR has launched a nationwide obesity study to tackle India’s rising waistline and identify the most effective weight-loss methods.

The Indian Council of Medical Research has launched a nationwide exercise to find out what actually works to reduce weight and lower related health risks, as India faces a growing obesity challenge. Nearly one in four adults in the country is now overweight or obese, and the trend is driving more cases of diabetes, high blood pressure and heart disease.

The move comes as there is still no clear, unified answer on which weight-loss approach works best or for whom, despite years of research, fitness plans and awareness campaigns. Through a large pooled analysis, ICMR wants researchers to contribute data from multiple studies so it can compare interventions such as diet, physical activity, behavioural methods and multi-component programmes.

The analysis will go beyond weight loss and also track blood sugar, blood pressure and cholesterol levels. ICMR’s effort is aimed at building India-specific evidence that can guide future treatment guidelines and public health strategies, especially as obesity continues to rise across both urban and rural areas.

India’s Waistline Question Becomes a Public Health Priority

The scale of the problem has made abdominal obesity a serious concern in the country’s health conversation. The initiative reflects a broader shift toward understanding not just how much weight people lose, but which interventions improve overall metabolic health.

ICMR Seeks Data for Obesity Study

ICMR has invited researchers to share data for the collaborative analysis, which is expected to strengthen the country’s response to overweight and obesity. The findings are likely to shape more targeted approaches for prevention and management in the future.

Read Next

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care
News
July 17, 2026

Menthra launches Menthra Care in India, the human layer that turns everyday support into real continuity of care

Menthra, an AI-powered emotional wellbeing platform, today announced the launch of Menthra Care in India, expanding its platform to connect users with verified therapists, coaches, licensed clinical professionals and care organisations when they need support beyond an AI companion. The launch follows Menthra’s India debut in June, which saw tens of thousands of users join […]
Article by: IMT News Desk
IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care
News
July 17, 2026

IHH FutureHealth Now 2026 Explores How Affordability, AI and Precision Medicine Will Shape the Future of Care

Against a backdrop of geopolitical uncertainty, supply chain disruptions and rapid advances in artificial intelligence (AI) and precision medicine, FutureHealth.Now provided a platform for industry leaders to explore how innovation, technology and new models of care can help tackle rising healthcare costs, workforce pressures and growing demand for services across the region. At his opening […]
Article by: IMT News Desk
Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill
News
July 16, 2026

Novo Nordisk Wins EU Approval for Wegovy Weight-Loss Pill

Novo Nordisk has secured European Commission approval for its once-daily Wegovy pill, giving the Danish drugmaker a major boost in the fast-growing obesity-treatment market. The approval makes it the first oral GLP-1 weight-loss treatment cleared in the European Union for adults with obesity or overweight who also have at least one weight-related health condition. The […]
Article by: IMT News Desk
Sun Pharma Wins South Africa Approval to Launch Generic Ozempic
News
July 16, 2026

Sun Pharma Wins South Africa Approval to Launch Generic Ozempic

India’s Sun Pharmaceutical Industries has received approval from South Africa’s health regulator to manufacture and sell a generic version of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy, expanding its presence in the fast-growing GLP-1 market. The South African Health Products Regulatory Authority’s clearance allows Sun Pharma to market the injectable treatment for […]
Article by: IMT News Desk